Making Drugs and Vaccines Accessible, Affordable – Where does India Stand?Richa Chintan·June 10, 2021
Plea filed in SC seeking directions to Centre to issue compulsory licenses for patents on Remdesivir, Favipiravir, TocilizumabThe Leaflet·April 29, 2021
Statement by Indian Civil Society: Need for open innovation and knowledge sharing for COVID-19 healthcare through Indian IP lawsThe Leaflet·June 24, 2020